On Monday, the US Supreme Court issued a temporary order restoring broad access to the abortion pill mifepristone. This ruling blocks a recent federal appeals court decision that sought to impose new restrictions on its availability. Women can now obtain mifepristone at pharmacies or through the mail without needing an in-person visit to a doctor. The majority of abortions in the United States are performed using medications, primarily mifepristone combined with another drug, misoprostol. This access has been crucial in mitigating the effects of abortion bans enacted by many Republican-led states following the Supreme Court's 2022 decision to overturn Roe v. Wade, which previously protected abortion rights. In Louisiana, a lawsuit aimed to restrict access to mifepristone, claiming that its availability undermined the state's abortion ban. Conversely, some Democratic-led states are implementing laws to provide legal protections for telehealth prescriptions of these medications. Justice Samuel Alito's order will remain in effect for another week while the court considers responses from both sides.